Risk for Death, Cardiovascular Death Lower for OSA Patients Using CPAP
Reduction seen in low-density coronary artery plaque volume with CPAP and with use of CPAP and GLP-1-mediated weight loss
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use
Adverse Association Identified for Calcium Channel Blocker Use, Glaucoma
CCB use also linked to thinner macular ganglion cell-inner plexiform layer, macular retinal nerve fiber layer thickness
Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
Population attributable risk percentage for antepartum anemia and SMM highest for multiracial, Black, Hispanic patients
Food Additive Emulsifier Intake Linked to Risk for CVD
Higher intake of celluloses (E460 to E468) positively associated with higher risks for CVD and coronary heart disease
Upfront Combo Lipid-Lowering Therapy Best for Acute Coronary Syndrome
Combination approach better than statin monotherapy for all-cause mortality at one, three, and five years in acute coronary syndromes
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients
Statin Use Linked to Reduced Risk for CRC Incidence, Mortality in Patients With IBD
Benefit for incident CRC was duration-dependent, with significantly reduced risk after two or more years of use
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Availability of CVD Meds Varies by Low-Cost Generic Program
Variation in coverage seen by program, drug, and cardiovascular disease condition
